Efficacy of Combination Chemotherapy with Irinotecan (CPT-11) plus Capecitabine in Patients with Metastatic or Advanced Colorectal Carcinoma - a Dual-centre Phase II Study: the MAC-6

Clinical Oncology

Volumn 20, Issue 2, 2008, Pages 168-175

  Choi, C K K ^a   Chan, R T T ^a   Tung, S Y ^b   Lui, L ^a   Siu, S ^a   Au, G K H ^a   Ho, J W C ^a   Law, W L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Capecitabine; CPT 11; irinotecan; metastatic colorectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; IRINOTECAN; LEVAMISOLE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS POTENTIAL; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NAUSEA AND VOMITING; NEUTROPENIA; NEUTROPHIL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SAMPLE SIZE; SIDE EFFECT; THROMBOCYTE; THROMBOCYTOPENIA; TREATMENT DURATION; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SALVAGE THERAPY; SURVIVAL RATE;

EID: 39049165189     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.11.008     Document Type: Article

References (14)

1. The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10 (1992) 896-903
2. The Advanced Colorectal Cancer Meta-Analysis Project. Meta-analysis of randomised trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12 (1994) 960-969
3. Scheithauer W., Rosen H., Kornek G., et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 306 (1993) 752-755
4. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomised trial. J Clin Oncol 10 (1992) 904-911
5. Moertel C.G. Chemotherapy for colorectal cancer. N Eng J Med 330 (1994) 1136-1142
6. Cancer of the Colon and Rectum. The Seventh King's Fund Forum. Consensus Statement. King's Fund, 1990.
7. Begent R.H.J. Colorectal cancer. Br Med J 305 (1992) 246-249
8. Rougier P., Van Cutsem E., Bajetta E., et al. Randomised trial of irinotecan vs fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352 (1998) 1407-1412
9. Douillard J.Y., Cunningham D., Roth A.D., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355 (2000) 1041-1047
10. Cao S., Hapke G., and Rustum Y.M. Enhanced antitumor activity of Xeloda by irinotecan in nude mice bearing human A253 FaDu head and neck xenografts. (abstract 464). Proc Am Soc Cancer Res 42 (2001) 86
11. Kerr D.J., Ten Bokkel Huinink W.W., Ferry D.R., et al. A phase I/II study of CPT-11 in combination with capecitabine as first-line chemotherapy for metastatic colorectal cancer. (abstract 643). Proc Am Soc Clin Oncol 21 (2002) 161a
12. Jordan K., Grothey A., Keliner O., et al. Randomized phase II trial of capecitabine plus irinotecan vs capecitabine plus oxaliplatin as first-line therapy in advanced colorectal cancer. Results of an interim analysis. (abstract 2225). Proc Am Soc Clin Oncol 21 (2002) 103b
13. Borner M.M., Bernhard J., Dietrich D., et al. A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Ann Oncol 16 (2005) 282-288
14. Saltz L.B., Cox J.V., Blanke C., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343 (2000) 905-914